Examination of Trends in Colorectal Cancer Patients' Clinical Study Experiences
Not yet recruiting
- Conditions
- Colorectal Cancer
- Registration Number
- NCT05891730
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical study participation percentages haven't always been fully representative of a given demographic.
Participation in this observational clinical research is extremely valuable since it allows people with colorectal cancer to contribute their own experiences and unique viewpoints.
These vital contributions have the potential to affect the development of novel therapies and support services dramatically.
Trial's findings will be critical in furthering the understanding of colorectal cancer, ultimately leading to better patient outcomes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Participant has a diagnosis of colorectal cancer
- Patient has self-identified as planning to enroll in a clinical trial for colorectal cancer
- Patient is at least 18 years of age
Exclusion Criteria
- Inability to perform regular electronic reporting
- Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
- Pregnant or lactating woman
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who decide to enroll in a colorectal cancer clinical study. 3 months Number of colorectal cancer patients who remain in clinical trial until completion. 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States